Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$31.15 - $33.39 $872 - $934
-28 Reduced 1.15%
2,402 $79,000
Q3 2022

Oct 27, 2022

SELL
$30.9 - $33.55 $11,093 - $12,044
-359 Reduced 12.87%
2,430 $76,000
Q2 2022

Aug 01, 2022

BUY
$23.75 - $31.69 $2,018 - $2,693
85 Added 3.14%
2,789 $84,000
Q1 2022

May 11, 2022

SELL
$19.97 - $26.94 $13,000 - $17,537
-651 Reduced 19.4%
2,704 $70,000
Q4 2021

Feb 11, 2022

SELL
$17.46 - $21.61 $5,028 - $6,223
-288 Reduced 7.91%
3,355 $69,000
Q3 2021

Nov 10, 2021

SELL
$17.35 - $22.5 $401,236 - $520,335
-23,126 Reduced 86.39%
3,643 $70,000
Q2 2021

Aug 05, 2021

SELL
$18.01 - $28.32 $1,134 - $1,784
-63 Reduced 0.23%
26,769 $593,000
Q1 2021

Apr 28, 2021

SELL
$19.76 - $29.89 $25,747 - $38,946
-1,303 Reduced 4.63%
26,832 $704,000
Q4 2020

Feb 04, 2021

BUY
$15.73 - $21.66 $30,720 - $42,301
1,953 Added 7.46%
28,135 $526,000
Q3 2020

Nov 10, 2020

BUY
$13.54 - $26.41 $286,668 - $559,152
21,172 Added 422.59%
26,182 $445,000
Q2 2020

Aug 07, 2020

BUY
$7.84 - $23.29 $28,851 - $85,707
3,680 Added 276.69%
5,010 $116,000
Q1 2020

May 13, 2020

SELL
$5.57 - $11.5 $3,854 - $7,958
-692 Reduced 34.22%
1,330 $11,000
Q4 2019

Feb 04, 2020

BUY
$7.9 - $10.14 $2,259 - $2,900
286 Added 16.47%
2,022 $20,000
Q3 2019

Nov 08, 2019

SELL
$9.17 - $12.01 $2,879 - $3,771
-314 Reduced 15.32%
1,736 $16,000
Q2 2019

Aug 13, 2019

SELL
$10.88 - $17.6 $3,383 - $5,473
-311 Reduced 13.17%
2,050 $25,000
Q1 2019

May 08, 2019

SELL
$15.51 - $17.61 $3,722 - $4,226
-240 Reduced 9.23%
2,361 $41,000
Q3 2018

Nov 01, 2018

BUY
$14.85 - $16.35 $17,820 - $19,620
1,200 Added 85.65%
2,601 $38,000
Q2 2018

Aug 08, 2018

SELL
$13.8 - $16.8 $22,935 - $27,921
-1,662 Reduced 54.26%
1,401 $22,000
Q1 2018

May 08, 2018

SELL
$13.8 - $16.2 $6,941 - $8,148
-503 Reduced 14.11%
3,063 $44,000
Q4 2017

Feb 02, 2018

SELL
$13.55 - $15.8 $11,571 - $13,493
-854 Reduced 19.32%
3,566 $50,000
Q3 2017

Nov 13, 2017

BUY
$13.45 - $14.35 $59,449 - $63,427
4,420
4,420 $63,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.